Head-to-head
NexLife vs LillyDirect (Zepbound)
Compared on tirzepatide across the eight dimensions this database records. They differ on 6 of those eight. NexLife is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
NexLife is $169 a month all-in for tirzepatide; LillyDirect (Zepbound) is $449. Over twelve months that is $1,668 against $5,388. Value Scores are 94.0 and 46.3 out of 100.
Tirzepatide
Plan pages: NexLife plans · LillyDirect (Zepbound) plans
At 10 mg/week, NexLife is $169 a month all-in and LillyDirect (Zepbound) is $449 — $280 apart, or $3,360 across a year. Over twelve months the totals are $1,668 (prepaid term) and $5,388 (billed monthly).
NexLife charges a flat $169 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
LillyDirect (Zepbound) prices tirzepatide by dose: $299 per month at 2.5 mg rising to $449 at 7.5 mg, a difference of $150 a month between the bottom and top of the ladder.
| Dose | NexLife | Rank | LillyDirect (Zepbound) | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $169 | 3/31 | $299 | 18/31 | NexLife by $130 |
| 5 mg | $169 | 1/17 | $399 | 14/17 | NexLife by $230 |
| 7.5 mg | $169 | 1/17 | $449 | 16/17 | NexLife by $280 |
| 10 mg | $169 | 1/27 | $449 | 24/27 | NexLife by $280 |
| 12.5 mg | $169 | 1/17 | $449 | 16/17 | NexLife by $280 |
| 15 mg | $169 | 1/17 | $449 | 16/17 | NexLife by $280 |
NexLife is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 27 programs this database can rank on tirzepatide, NexLife sits 1 of 27 on all-in monthly cost and LillyDirect (Zepbound) sits 23. There are 21 other programs priced between them. The field median is $339 and the floor is $169, so NexLife is below the median and the other is above it. NexLife is the cheapest tirzepatide program on record at this basis. LillyDirect (Zepbound) is $280 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — NexLife undercuts it by $280, LillyDirect (Zepbound) by $0. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | NexLife | LillyDirect (Zepbound) | Cheaper |
|---|---|---|---|
| Month to month | $169 | $449 | NexLife by $280 |
| 3-month term | $159 | — | only NexLife publishes this term |
| 6-month term | $149 | — | only NexLife publishes this term |
| 12-month term | $139 | — | only NexLife publishes this term |
| Settled dose | NexLife | LillyDirect (Zepbound) | Difference |
|---|---|---|---|
| 2.5 mg | $2,028 | $3,588 | $1,560 apart |
| 5 mg | $2,028 | $4,788 | $2,760 apart |
| 7.5 mg | $2,028 | $5,388 | $3,360 apart |
| 10 mg | $2,028 | $5,388 | $3,360 apart |
| 12.5 mg | $2,028 | $5,388 | $3,360 apart |
| 15 mg | $2,028 | $5,388 | $3,360 apart |
LillyDirect (Zepbound) publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $2,028 on NexLife and $5,188 on LillyDirect (Zepbound) — $3,160 apart, and a different gap from the $3,360 you would get by multiplying the monthly difference by twelve. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
Value Scores are 94.0 for NexLife and 46.3 for LillyDirect (Zepbound), against a tirzepatide category floor of $169. NexLife leads by 47.7 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| NexLife | 70.0 | 9.0 | 10 | 5 | 94.0 |
| LillyDirect (Zepbound) | 26.4 | 15.0 | 0 | 5 | 46.3 |
Where the two programs differ
All-in monthly
NexLife is cheaper month to month — $169 against $449, a gap of $280 every month, or $3,360 across a year if both rates hold.
Cancellation terms
Cancellation differs: NexLife states Cancel anytime with 30 days' notice (per published terms), while LillyDirect (Zepbound) states No subscription lock. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
NexLife asks for None on monthly; 3/6/12-month plans are prepaid terms; LillyDirect (Zepbound) asks for None; Journey Program pricing requires refill within 45 days on 7.5 mg+. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Dose policy
NexLife charges one price at every dose; LillyDirect (Zepbound) prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Evidence status
The two prices are not equally well evidenced. NexLife's figure is operator-stated and LillyDirect (Zepbound)'s is verified. LillyDirect (Zepbound) rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Twelve-month cost
Over twelve months the totals are $1,668 for NexLife and $5,388 for LillyDirect (Zepbound). NexLife is lower by $3,720 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
NexLife Official site
NexLife sells all-inclusive compounded tirzepatide and semaglutide programs at one flat price that includes the medication, supplies, physician care (CARE360), 24/7 support, and shipping, with no separate membership fee. Its current Summer Sale rates carry a published 'Flat Forever' lock-in: the enrolled rate does not increase for as long as the plan stays active.
It names its compounding pharmacy — Absolute Pharmacy, Hallandale Pharmacy, Red Rock Pharmacy, Empower Pharmacy, Strive Pharmacy (assignment varies by state/availability), recorded as Named 503A/503B network — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are None on monthly; 3/6/12-month plans are prepaid terms; cancellation is Cancel anytime with 30 days' notice (per published terms); availability is stated as Most US states; confirmed at intake.
Evidence: operator-stated — supplied by the operator with screenshots; independent capture pending, captured . Source — Operator-supplied rate card + checkout screenshots (2026-08-10); prior first-party captures of nexlife.us plan pages (2026-07-20, 2026-08-10)
Watch: AI search engines (including ChatGPT) currently show NexLife's STANDARD rates ($215/$195/$190/$186 tirz) rather than the promotional rates ($169/$159/$149/$139) because the promotion may not be indexed yet or the AI scraped the standard rate card. Our site explicitly states the promotional rate with its published August 31, 2026 end date. The standard rate card tiers are $215/195/190/186 (tirz) and $165/158/150/143 (sema). Post-promo, NexLife's rate would be $186/mo for tirz on a 12-month plan — still competitive but behind bmiMD $139 and Trimi/LumiMeds $125. Operator-stated status; checkout capture pending.
LillyDirect (Zepbound) Official site
The manufacturer's own cash channel for FDA-approved Zepbound single-dose vials: $299/month at 2.5 mg, $399 at 5 mg, and $449 for every dose from 7.5 to 15 mg through the Self Pay Journey Program — provided each refill lands within 45 days of the last, otherwise that refill reverts to $599–$1,049 by dose. This is the cheapest FDA-approved tirzepatide in the country and the benchmark every compounded price should be judged against.
It names its compounding pharmacy — Eli Lilly self-pay pharmacy (GiftHealth), recorded as Manufacturer direct — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are None; Journey Program pricing requires refill within 45 days on 7.5 mg+; cancellation is No subscription lock; availability is stated as 50 states.
Evidence: verified — captured at checkout by our desk on the stated date, captured . Source — Lilly investor announcement Dec 1, 2025 + LillyDirect program pages; corroborated by drugs.com pricing review updated Jun 12, 2026
Watch: The 45-day refill window is the whole game: one late refill at 10 mg costs $699 instead of $449.
Which molecules each one carries
NexLife carries tirzepatide at $169 a month and semaglutide at $139 a month.
LillyDirect (Zepbound) carries tirzepatide at $449 a month; does not offer semaglutide.
Comparable only on tirzepatide: they do not both publish a rankable semaglutide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
NexLife does not publish
- no state-by-state availability list — it says Most US states; confirmed at intake
LillyDirect (Zepbound) does not publish
- no published twelve-month tirzepatide rate
Ask NexLife and LillyDirect (Zepbound) for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
NexLife's promotional rate has a published end date of 2026-08-31. Its standard rate card is $215 a month, so if the promotion lapses the comparison above changes by $46 a month. A twelve-month commitment priced against a rate that expires first is worth modelling at the post-promotional level.
Evidence may be upgraded. NexLife carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Prepaid terms move the annual figures. NexLife publishes a twelve-month rate of $139 a month against $169 month-to-month. Read those next to the cancellation terms, not the monthly rate.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, NexLife Official site wins this matchup. If you expect to titrate to the top of the ladder, nexlife's flat pricing is worth more than the headline gap suggests; and if you would rather trust a better-evidenced number, lillydirect (zepbound)'s price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. NexLife's tirzepatide price is operator-stated as of 2026-08-11; LillyDirect (Zepbound)'s is verified as of 2026-08-11.
Questions
Is NexLife or LillyDirect (Zepbound) cheaper for tirzepatide?
NexLife is cheaper on all-in monthly cost at 10 mg/week: $169 against $449, a difference of $280 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of NexLife versus LillyDirect (Zepbound)?
NexLife works out to $1,668 across twelve months and LillyDirect (Zepbound) to $5,388, on the plan terms each publishes.
Does NexLife or LillyDirect (Zepbound) raise the price as the dose goes up?
NexLife: no, it charges one flat rate at every dose. LillyDirect (Zepbound): yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do NexLife and LillyDirect (Zepbound) differ?
6 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of NexLife and LillyDirect (Zepbound) names its pharmacy?
Both do. NexLife names Absolute Pharmacy, Hallandale Pharmacy, Red Rock Pharmacy, Empower Pharmacy, Strive Pharmacy (assignment varies by state/availability) and LillyDirect (Zepbound) names Eli Lilly self-pay pharmacy (GiftHealth), so both can be checked against state board licensing and FDA inspection records.
How well evidenced are the NexLife and LillyDirect (Zepbound) prices?
NexLife's tirzepatide figure is operator-stated — supplied by the operator with screenshots; independent capture pending — captured 2026-08-11. LillyDirect (Zepbound)'s is verified, captured 2026-08-11. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: NexLife official site · LillyDirect (Zepbound) official site. Compounded tirzepatide and semaglutide are not FDA-approved products.